Paulina Nunez Badinez

Dr. Paulina Nunez Badinez

Merz Therapeutics GmbH, Frankfurt am Main, Germany
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2017 in eLife
Verified
Journal Article
Open access
SDSandeep Dembla
Sandeep Dembla
MBMarc Behrendt
Marc Behrendt
FMFlorian Mohr
Florian Mohr
CGChristian Goecke
Christian Goecke
JSJulia Sondermann
Julia Sondermann
JOJohannes Oberwinkler
Johannes Oberwinkler
Opioids, agonists of µ-opioid receptors (µORs), are the strongest pain killers clinically available. Their action includes a strong central component, which also causes important adverse effects. However, µORs are also found on the peripheral endings of nociceptors and their activation there produces meaningful analgesia. The cellular mechanisms downstream of peripheral µORs are not well understood. Here, we show in neurons of murine dorsal root ganglia that pro-nociceptive TRPM3 channels, present in the peripheral parts of nociceptors, are strongly inhibited by µOR activation, much more than other TRP channels in the same compartment, like TRPV1 and TRPA1. Inhibition of TRPM3 channels occurs via a short signaling cascade involving Gβγ proteins, which form a complex with TRPM3. Accordingly, activation of peripheral µORs in vivo strongly attenuates TRPM3-dependent pain. Our data establish TRPM3 inhibition as important consequence of peripheral µOR activation indicating that pharmacologically antagonizing TRPM3 may be a useful analgesic strategy.

3 March 2021 in Pain
Verified
Journal Article
Open access
Paulina Nunez BadinezPaulina Nunez Badinez
Paulina Nunez Badinez
BLBianca De Leo
Bianca De Leo
ALAlexis Laux-Biehlmann
Alexis Laux-Biehlmann
AHAnja Hoffmann
Anja Hoffmann
TZThomas M. Zollner
Thomas M. Zollner
JNJens Nagel
Jens Nagel
Endometriosis (ENDO) and interstitial cystitis/bladder pain syndrome (IC/BPS) are chronic pain conditions for which better treatments are urgently needed. Development of new therapies with proven clinical benefit has been slow. We have conducted a review of existing preclinical in vivo models for ENDO and IC/BPS in rodents, discussed to what extent they replicate the phenotype and pain experience of patients, as well as their relevance for translational research. In 1009 publications detailing ENDO models, 41% used autologous, 26% syngeneic, 18% xenograft, and 11% allogeneic tissue in transplantation models. Intraperitoneal injection of endometrial tissue was the subcategory with the highest construct validity score for translational research. From 1055 IC/BPS publications, most interventions were bladder-centric (85%), followed by complex mechanisms (8%) and stress-induced models (7%). Within these categories, the most frequently used models were instillation of irritants (92%), autoimmune (43%), and water avoidance stress (39%), respectively. Notably, although pelvic pain is a hallmark of both conditions and a key endpoint for development of novel therapies, only a small proportion of the studies (models of ENDO: 0.5-12%, models of IC/BPS: 20-44%) examined endpoints associated with pain. Moreover, only 2% and 3% of publications using models of ENDO and IC/BPS investigated non-evoked pain endpoints. This analysis highlights the wide variety of models used, limiting reproducibility and translation of results. We recommend refining models so that they better reflect clinical reality, sharing protocols, and employing standardized endpoints to improve reproducibility. We are addressing this in our project IMI-PainCare/Translational Research in Pelvic Pain (TRiPP).

Verified
Journal Article
Open access
PDF file
MTMiguel A Tejada
Miguel A Tejada
CACarles Antunez
Carles Antunez
Paulina Nunez BadinezPaulina Nunez Badinez
Paulina Nunez Badinez
BLBianca De Leo
Bianca De Leo
Philippa SaundersPhilippa Saunders
Philippa Saunders
RGRaul Gomez
Raul Gomez
Chronic pain induced by endometriosis is a maladaptive pain experienced by half of women with this disease. The lack of pharmacological treatments suitable for the long-term relief of endometriosis-associated pain, without an impact on fertility, remains an urgent unmet need. Progress has been slowed by the absence of a reproducible rodent endometriosis model that fully replicates human physiopathological characteristics, including pain symptoms. Although pain assessment in rodents is a complicated task requiring qualified researchers, the choice of the behavioral test is no less important, since selecting inappropriate tests can cause erroneous data. Pain is usually measured with reflex tests in which hypersensitivity is evaluated by applying a noxious stimulus, yet this ignores the associated emotional component that could be evaluated via non-reflex tests. We conducted a systematic review of endometriosis models used in rodents and the number of them that studied pain. The type of behavioral test used was also analyzed and classified according to reflex and non-reflex tests. Finally, we determined the most used reflex tests for the study of endometriosis-induced pain and the main non-reflex behavioral tests utilized in visceral pain that can be extrapolated to the study of endometriosis and complement traditional reflex tests.

8 December 2017 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Paulina Nunez BadinezPaulina Nunez Badinez
Paulina Nunez Badinez
HSHugo Sepúlveda
Hugo Sepúlveda
EDEmilio Diaz
Emilio Diaz
WGWolfgang Greffrath
Wolfgang Greffrath
RTRolf‐Detlef Treede
Rolf‐Detlef Treede
BZBrigitte van Zundert
Brigitte van Zundert

21 February 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
MTMiguel A Tejada
Miguel A Tejada
ALAna Isabel Santos Llamas
Ana Isabel Santos Llamas
LELesley Escriva
Lesley Escriva
JTJuan J. Tarín
Juan J. Tarín
ACAntonio Cano
Antonio Cano
RGRaul Gomez
Raul Gomez
The aim of this study was to develop and refine a heterologous mouse model of endometriosis-associated pain in which non-evoked responses, more relevant to the patient experience, were evaluated. Immunodeficient female mice (N = 24) were each implanted with four endometriotic human lesions (N = 12) or control tissue fat (N = 12) on the abdominal wall using tissue glue. Evoked pain responses were measured biweekly using von Frey filaments. Non-evoked responses were recorded weekly for 8 weeks using a home cage analysis (HCA). Endpoints were distance traveled, social proximity, time spent in the center vs. outer areas of the cage, drinking, and climbing. Significant differences between groups for von Frey response, climbing, and drinking were detected on days 14, 21, and 35 post implanting surgery, respectively, and sustained for the duration of the experiment. In conclusion, a heterologous mouse model of endometriosis-associated evoked a non-evoked pain was developed to improve the relevance of preclinical models to patient experience as a platform for drug testing.

3 July 2025 in Molecular Human Reproduction
Verified
Journal Article
Open access
KDKelsi N Dodds
Kelsi N Dodds
VFVictor Fattori
Victor Fattori
NANick A Andrews
Nick A Andrews
CACaroline B Appleyard
Caroline B Appleyard
JCJulie A Christianson
Julie A Christianson
PVPaola Viganó
Paola Viganó
Pain is a debilitating symptom of endometriosis, and its mechanisms are often explored using rodent models. However, a lack of harmonization amongst models and behavioural measures, in addition to inconsistent reporting, might limit the overall clinical relevance and hinder translation of findings. An additional challenge is accurately linking rodent behaviour to human experiences of endometriosis. This study aimed to: (i) review current measures of pain-associated behaviours used in endometriosis studies; (ii) recommend best practices for each method and their suitability to study endometriosis-associated pain; and (iii) develop internationally agreed-upon standard operating procedures (‘EPHect-EM-Pain SOPs’). The World Endometriosis Research Foundation (WERF) assembled an international working group, from which a ‘pain behaviour working group’ consisting of experts in the field was established. The group used additional consultation from experimental pain model scientists in the broader field. Stimulus-evoked (reflexive) and stimulus-independent (spontaneous) measures are currently used to assess pain-associated behaviours in rodents with experimental endometriosis. All existing methods offer advantages and limitations regarding ethological relevance, output quality, and equipment/training requisites. Internationally standardized pain SOPs as well as summary documentation outlining the minimum and standard requirements for several behavioural measures were developed, as well as consensus recommendations on experimental designs and documentation. To more closely reflect the lived experiences of those with endometriosis, the consortium recommends that, following validation, multiple types of pain-related and/or parallel rodent behaviours (e.g. anxiety) should be quantified as surrogate outcome measures for endometriosis-associated pain. These harmonized methods and documentation for endometriosis research will facilitate essential comparisons among studies, improve translational applicability, and provide a superior holistic view of animal (and thus human) wellbeing.